 | • レポートコード：B-MOR-040926 • 出版社/出版日：Mordor Intelligence / 2018年2月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、再生医療の世界市場について調べ、再生医療の世界規模、市場動向、市場環境、技術別（細胞療法、バイオマテリアル、生体組織工学）分析、用途別（骨補填材、骨関節疾患、皮膚科、循環器科、脳神経科）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・再生医療の世界市場インサイト ・再生医療の世界市場環境 ・再生医療の世界市場動向 ・再生医療の世界市場規模 ・再生医療の世界市場規模：技術別（細胞療法、バイオマテリアル、生体組織工学） ・再生医療の世界市場規模：用途別（骨補填材、骨関節疾患、皮膚科、循環器科、脳神経科） ・再生医療の世界市場：地域別市場規模・分析 ・再生医療の北米市場規模・予測 ・再生医療のアメリカ市場規模・予測 ・再生医療のヨーロッパ市場規模・予測 ・再生医療のアジア市場規模・予測 ・再生医療の日本市場規模・予測 ・再生医療の中国市場規模・予測 ・再生医療のインド市場規模・予測 ・再生医療の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global regenerative medicine market has been estimated to reach USD 4.23 billion in 2023. The market is expected to register a CAGR of 14% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements.
Increasing adoption of stem cell technology
Increasing adoption of stem cell technology, increasing prevalence of chronic diseases, emerging applications of gene therapy in regenerative medicine are some of the driving factors for Global Regenerative Medicine market. Technological advances in regenerative medicine (stem cell, tissue engineering, and nanotechnology) and high investment & funding to support development of regenerative medicine are also fuelling the market growth.
Regulatory and ethical issues
Regulatory and ethical issues pertaining stem cell, tissues engineering and regenerative medicine are acting as a restraint for Regenerative Medicine market. High cost of treatments and less awareness about the regenerative medicine among people is further restraining the market.
North America to Dominate the Market
The Regenerative Medicine market is segmented by type of treatment and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the Regenerative Medicine market due to the increasing technological advancements and high investment & funding to support development of regenerative medicine. Asia-Pacific is also expected to propel the Regenerative Medicine market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing economic growth.
Key developments in the market
• In January, 2018: Medeor Therapeutics Awarded $18.8 Million From the California Institute for Regenerative Medicine
• In January, 2018: RepliCel Life Sciences Inc. formed a partnership with the private firm, China-based Yofoto Health Industry Co. Ltd for regenerative medicine
Major key players: ACELITY, OSIRIS THERAPEUTICS, INC., INTEGRA LIFESCIENCES CORPORATION, ASTRAZENECA, COOK BIOTECH INCORPORATED, ORGANOGENESIS INC. and MERCK & CO., INC. etc.
Reasons to purchase this report
• Market analysis for the Global Regenerative Medicine Market, with region-specific assessments and competition analysis on a global and regional scale.
• Analyzing various perspectives of the company with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet in excel.
Customization of the report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
レポート目次TABLE OF CONTENTS
1. INTRODUCTION
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCREASING ADOPTION OF STEM CELL TECHNOLOGY
6.1.2 TECHNOLOGICAL ADVANCES IN REGENERATIVE MEDICINE
6.2 MARKET RESTRAINTS
6.2.1 REGULATORY AND ETHICAL ISSUES
6.2.2 HIGH COST OF TREATMENTS AND LESS AWARENESS
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
7. MARKET SEGMENTATION
7.1 BY TYPE OF TECHNOLOGY
7.1.1 STEM CELL THERAPY
7.1.2 BIOMATERIAL
7.1.3 TISSUE ENGINEERING
7.2 BY TYPE OF APPLICATIONS
7.2.1 BONE GRAFT SUBSTITUTES
7.2.2 OSTEOARTICULAR DISEASES
7.2.3 DERMATOLOGY
7.2.4 CARDIOVASCULAR
7.2.5 CENTRAL NERVOUS SYSTEM
7.3 BY GEOGRAPHY
7.3.1 NORTH AMERICA
7.3.1.1 US
7.3.1.2 CANADA
7.3.1.3 MEXICO
7.3.2 EUROPE
7.3.2.1 FRANCE
7.3.2.2 UK
7.3.2.3 GERMANY
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF EUROPE
7.3.3 ASIA-PACIFIC
7.3.3.1 INDIA
7.3.3.2 CHINA
7.3.3.3 JAPAN
7.3.3.4 AUSTRALIA
7.3.3.5 SOUTH KOREA
7.3.3.6 REST OF APAC
7.3.4 MIDDLE EAST AND AFRICA
7.3.4.1 GCC
7.3.4.2 SOUTH AFRICA
7.3.4.3 REST OF MIDDLE EAST AND AFRICA
7.3.5 SOUTH AMERICA
7.3.5.1 BRAZIL
7.3.5.2 ARGENTINA
7.3.5.3 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITIONS
8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
8.3 NEW PRODUCT LAUNCHES
9. KEY PLAYERS
9.1 ACELITY
9.2 OSIRIS THERAPEUTICS
9.3 INTEGRA LIFESCIENCES CORPORATION
9.4 COOK BIOTECH INCORPORATED
9.5 ORGANOGENESIS INC
9.6 MERCK & CO
9.7 OTHERS
10. FUTURE OUTLOOK OF THE MARKET